Innoviva, Inc.
INVA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001080014
No open-market purchases or sales by Innoviva, Inc. insiders were filed in the last 90 days; 308 institutions reported holding it in 13F filings for Q2 2026, worth $1.69B in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Innoviva, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 198
- +6 vs. Q1 2023
- Shares held
- 70.6M
- +856.6K (+1.2%) vs. Q1 2023
- Total value
- $898.1M
- +$109.3M (+13.9%) vs. Q1 2023
- New holders
- 27
- 63 more added
- Sold out
- 21
- 80 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 308 | $1.69B |
| Q1 2026 | 285 | $1.76B |
| Q4 2025 | 280 | $1.50B |
| Q3 2025 | 263 | $1.38B |
| Q2 2025 | 266 | $1.47B |
| Q1 2025 | 247 | $1.24B |
| Q4 2024 | 236 | $1.24B |
| Q3 2024 | 221 | $1.41B |
| Q2 2024 | 213 | $1.20B |
| Q1 2024 | 216 | $1.11B |
| Q4 2023 | 197 | $1.16B |
| Q3 2023 | 193 | $892.4M |
| Q2 2023 | 198 | $898.1M |
| Q1 2023 | 193 | $789.0M |
| Q4 2022 | 208 | $1.01B |
| Q3 2022 | 213 | $901.8M |
| Q2 2022 | 219 | $1.17B |
| Q1 2022 | 236 | $1.49B |
| Q4 2021 | 218 | $1.23B |
| Q3 2021 | 208 | $1.18B |
| Q2 2021 | 184 | $939.5M |
| Q1 2021 | 177 | $842.1M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Innoviva, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −112,000−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −35,313−100.0% | Sold out |
| Truist Financial Corp | 0 | $0 | 0.00% | −33,726−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −32,036−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −27,923−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −23,860−100.0% | Sold out |
| NinePointTwo Capital | 0 | $0 | 0.00% | −23,093−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −21,736−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −20,538−100.0% | Sold out |
| Gallacher Capital Management LLC | 0 | $0 | 0.00% | −18,631−100.0% | Sold out |
| Acrisure Capital Management, LLC | 0 | $0 | 0.00% | −17,451−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −10,082−100.0% | Sold out |
| New Vernon Capital Holdings II LLC | 0 | $0 | 0.00% | −8,304−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −5,700−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −3,862−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −2,309−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −204−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −37−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Euclidean Technologies Management, LLC | – | – | – | – | Not filed |